{"DataElement":{"publicId":"6242599","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay Ten Year Local Recurrence Surgery Single Number","preferredDefinition":"The 10-year likelihood risk of local recurrence with breast-conserving surgery alone based on their  Oncotype DX breast cancer diagnostic assay result. The recurrence risk is calculated from the gene expression results and ranges from 0-100 percent.","longName":"LAB_ONCODX_TENY_SURG_NUM","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"6242598","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay Ten Year Local Recurrence Surgery Single Outcome","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen._A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one._A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period._Of or belonging to a restricted area or locality._Happening again (especially at regular intervals)._The branch of medical science that treats disease or injury by operative procedures._Not accompanied by another or others; exclusive of anyone or anything else._The result of an action.","longName":"2543047v1.0:6242596v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6242596","version":"1","preferredName":"Oncotype DX Breast Cancer Assay Ten Year Local Recurrence Surgery Single Outcome","preferredDefinition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.:A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.:A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.:Of or belonging to a restricted area or locality.:To come back or to return.:The branch of medical science that treats disease or injury by operative procedures.:Not accompanied by another or others; exclusive of anyone or anything else.:The result of an action.","longName":"6242596v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncotype DX Breast Cancer Assay","conceptCode":"C52159","definition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Ten","conceptCode":"C69122","definition":"A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Year","conceptCode":"C29848","definition":"A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B25FA54-0D82-02CB-E053-F662850AC4D0","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-05-01","modifiedBy":"ONEDATA","dateModified":"2018-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B25FA54-0D93-02CB-E053-F662850AC4D0","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-05-01","modifiedBy":"ZHANGWE","dateModified":"2018-07-05","changeDescription":"05012018 wz created for DCP SVAR NWU2015-06-04.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6013152","version":"1","preferredName":"Number","preferredDefinition":"A numeral or string of numerals expressing value, quantity, or identification.","longName":"6013152v1.0","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"19","minValue":null,"maxValue":null,"decimalPlace":"4","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233101","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F920A342-1134-2A6A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5CC656B6-21FF-60CD-E053-F662850ADF4C","latestVersionIndicator":"Yes","beginDate":"2017-10-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2017-10-30","modifiedBy":"TITARENI","dateModified":"2021-09-15","changeDescription":"11/19/18 jk upd reg status from Application to Qualified; added MCL CSI reference.  10/30/2017 wz created for DCP NWU datatype and size constraint. 09/15/2021 it added the number of decimal places (4)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5280815","version":"1","longName":"NWU2015-06-04","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"10 year risk of local recurre","type":"Preferred Question Text","description":"10 year risk of local recurrence with breast-conserving surgery alone (percent)","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B17F7E3-63ED-0BAC-E053-F662850ACD21","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-05-01","modifiedBy":"TITARENKOI","dateModified":"2020-07-16","changeDescription":"5/1/2018 created for DCP SVAR, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}